Levels of sPD-1, sPD-L1, sLAG-3, sICOS, sGITR and sCD86 were significantly higher in mismatch repair deficient tumors (p<0.05, Mann-Whitney U test) and difference in sGITRL was marginally significant (p=0.050, Mann-Whitney U test).
Excerpts
The difference did however become borderline significant after adjustment ( P = .05) (Table 2 ).
IT exhibited significantly superior BBS improvements compared to both ET and CT ( P < 0.001), while post-hoc comparisons indicated marginal significance between ET and CT ( P = 0.05).
The ANOVA of the regression model indicates that the model was highly significant at P < 0.05.
A borderline significant (Rho=0.26; p=0.05) association was observed between the arterial and muscular expression of CDKN2A/p16 INK4a ( Suppl.
In both genotypes, these epoxides had a decreasing trend in response to ischemia that was not statistically significant ( P > 0.05; Fig 7A ).
This pattern remained highly significant (p ≤ 0.05) across the unadjusted model, demographically adjusted model, and fully adjusted model, confirming NEE as an independent predictor of bone health risk, distinct from age, sex, and metabolic factors.
Ever-use of systemic HC was associated with earlier FS (39.3 vs 43.4 years), but this was marginally significant (linear regression, estimate = 2.1, p = 0.05; figure ).
Results showed a significant trend (YNM > OM > ONM) in the neural alignment of LI_intra in LAN, CON, FPN, DMN (all J–T statistics < − 1.666, all FDR-corrected P < 0.05) and LI_he in CON, DAN, FPN, and DMN (all J–T statistics < − 1.741, all FDR-corrected P < 0.05).
Among the 38 genes in the TRAIL pathway, seven genes achieved nominally significant association with hip OF ( p <0.05); the TNFSF10 ( TRAIL ) gene obtained the most significant p value ( p = 1.70×10 −4 ).
Mortality trend analysis The linear regression analysis for whole Italy showed an increasing trend over all analysed period (males APC 17%, females APC 18.6%, both p < 0.05) (see Figs. 2 and 3 , both showing annual AMR and modelled by regression analysis).
Body Composition and Cardiometabolic Health NC members had significantly higher percent body fat ( P < 0.001) and marginally significant higher diastolic blood pressure ( P = 0.05), but lower waist-to-hip ratio (0.87 vs 0.89, P = 0.04) than CC (Table 2 ).
approached significanceP <0.05
No significant difference was found for sleep- and other medication or for any comorbidities (although associations with self-reported depression and psychosis approached significance P <0.05).
Subgroup differences for glucose iAUC were borderline significant ( p = 0.05). 3.5.7.
Both cell types showed a markedly significant decrease ( p < 0.05) in the basal OCR after a 24 h combination treatment compared with the untreated control, and not surprisingly, we also observed a significant decrease ( p < 0.05) in the ECAR (extracellular acidic ratio; an indicator of glycolysis flux) following a combination treatment in both cell types ( supporting information, Figure S9 ).
The findings for ‘own promotion’ indicated that detailing produced a highly significant positive impact on new prescriptions for Lipitor and Crestor (p<0.05), while results were not significant for Vytorin. ‘Competitive’ detailing had a significant negative impact on new prescription for Vytorin (p<0.05) whereas results were not significant for the other two brands.
This difference is at the limit of significance (test Chi 2 p = 0.05).
Among these, VaTrihelix6 (8.8-fold), VaTrihelix15 (7.5-fold), VaTrihelix19 (8.7-fold), VaTrihelix28 (16-fold), and VaTrihelix30 (6.5-fold) displayed highly significant up-regulation ( p < 0.05).
The analysis outputs included the z-value, indicating trend direction and strength, and the p-value, assessing statistical significance ( p < 0.05 denotes a significant trend) [ 61 ].
In addition, there is no significant difference in the expression level of SCX among all groups, although an increasing trend was observed in the PLCL/COL+Fmod group ( p > 0.05).
The 71–80 and 81–90-year-old groups showed a favorable trend in terms of recurrence after the first procedure, 16% and 0%, respectively, compared to 29–42% in the other groups (p<0.05), except for the 21–30-year-old group in which 9 patients presented with a recurrence rate of 0%.
Quantitative analysis showed highly significant increase in the areas of fibrosis in group II compared to other groups (p<0.05.) These findings represent a valuable tool for Zinc-based therapy in the future after clinical trials to adjust the dose and ensure patient’s safety.
Only a near-significant effect for baseline beta was found, showing a slight increase over the sessions with exclusion of comorbid disorders, F (1, 796.367) = 3.862, p = 0.050, b = 0.00095, 95% CI = [0.000001 to 0.001903].
Interestingly, those who presented with weight loss were less likely to have malignancy (malignant, 4%; non-malignant, 18%), although this did not reach statistical significance ( p = 0.05).
showed a trendp=0.05
The reduction in fetal body weight in the progesterone-reduced group at 21 dg did not reach statistical significance (p=0.07) but showed a trend to reduce (Mann-Kendall test; correlation=0.8, p=0.05).